PDF
(154KB)
i
This article has been updated.
A Correction to this article was published on .
i
The Original Article was published on
i
The Original Article was published on
i
This article has been updated
i
This article was retracted on
i
This article has been updated
Abstract
Hexavalent chromium [Cr(VI)] bioreduction produces soluble Cr(III)-organic complexes. The Cr(III)-organic complexes are relatively stable once they are formed, and no data about their toxicity were reported. Therefore, this study aims to investigate the bioavailability and toxicity of the soluble Cr(III)-organic complexes. Saccharomyces cerevisiae L-1 wild type yeast strain was chosen as the model organism and Cr(III)-citrate was selected as the representative compound of the Cr(III)-organic complexes. The short-term chronic aquatic toxicity tests of the Cr(III)-citrate was explored by measuring growth inhibition, direct viable cell count, dry biomass, biosorption, and the amount of CO2 production. Cr(III)-citrate exerted a toxicity of 51mg/L with an EC50, which was calculated from the percent growth inhibition. These toxicity data would be helpful to define the toxic potential of the organo-chromium-III compounds in the environment.
Keywords
Cr(III)-organic complexes
/
Saccharomyces cerevisiae
/
toxicity
/
EC50
/
bioavailability
Cite this article
Download citation ▾
Nivedita CHATTERJEE, Zejiao LUO,.
Exposure-response of Cr(III)-organic complexes
to Saccharomyces cerevisiae.
Front. Environ. Sci. Eng., 2010, 4 (2) : 196-202 DOI:10.1007/s11783-010-0008-5
CHANGE HISTORY
A Correction to this paper has been published:
https://doi.org
The Retraction Note was updated to reflect reception of statements of disagreement from all authors.
This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org